An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer [0.03%]
基于免疫原性细胞死亡的特征预测三阴性乳腺癌的预后和免疫图谱
Xiyao Zhang,Miao Cao,Lulu Wu et al.
Xiyao Zhang et al.
Background: Triple-negative breast cancer (TNBC) represents a breast cancer subtype lacking three essential biomarkers: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER...
Integrative analysis identifies ALDOA and PGK1 as prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma [0.03%]
整合分析鉴定出ALDOA和PGK1是口腔鳞状细胞癌的预后生物标志物和治疗靶点
Wenyan Kang,Yanan Hou,Liling Xiang et al.
Wenyan Kang et al.
Background: Oral squamous cell carcinoma (OSCC) is associated with high mortality and limited effective targeted therapies. Although metabolic reprogramming is closely linked to malignancy, the key metabolic regulators th...
ZFP36 suppresses lung adenocarcinoma progression by mediating ROS-induced autophagy and ferroptosis [0.03%]
ZFP36通过介导ROS诱导的自噬和铁死亡抑制肺腺癌进展
Li Li,Yiru Yin,Zixuan Zhang et al.
Li Li et al.
Background and objective: As a tumor suppressor in lung adenocarcinoma (LUAD), ZFP36 is an RNA-binding protein that destabilizes oncogenic mRNAs. However, the precise mechanisms underlying its tumor-suppressive function r...
Anti-proliferation effects of oxaliplatin in combination with the probiotic Lactobacillus acidophilus in colorectal cancer cells [0.03%]
乳酸菌酸性乳杆菌联合奥沙利铂对结直肠癌细胞增殖的抑制作用
Saba Hajazimian,Alireza Isazadeh,Farshid Oruji et al.
Saba Hajazimian et al.
Background: Chemotherapy is prevalent as a key therapeutic method in the field of cancer treatment. However, the efficacy of colorectal cancer therapy is diminished because of the emergence of drug resistance. Combination...
Microbiome and peptide alterations in children with acute lymphoblastic leukemia: current insights and future directions [0.03%]
儿童急性淋巴细胞白血病的微生物组和肽变化:当前见解与未来方向
Zuzanna Zakrzewska,Oliwia Boruta,Dominika Skupień et al.
Zuzanna Zakrzewska et al.
Acute lymphoblastic leukemia (ALL) is the most common type of pediatric leukemia, yet the mechanisms of leukemogenesis remain incompletely comprehended. Since the concept of brain-gut-microbiome has been established, microbiota dysbiosis ha...
Early kinetics of CA19-9 and CEA after 5-FU-based chemotherapy for gastrointestinal cancers [0.03%]
基于5-氟尿嘧啶的化疗后胃肠肿瘤患者CA19-9和CEA早期变化动力学分析
Sebastian Lange,Patrick Wenzel,Christof Winter et al.
Sebastian Lange et al.
Introduction: In gastrointestinal oncology, serum tumor markers such as CEA and CA19-9 are typically monitored over several weeks to assess therapeutic efficacy. The immediate impact of cytotoxic therapy on these serum tu...
Integrated scissor and CIBERSORTx analyses reveals fibroblast subpopulations and biomarkers in stomach adenocarcinoma [0.03%]
整合剪切和CIBERSORTx分析揭示胃腺癌中的纤维细胞亚群和生物标志物
Siyi Wu,Manzhong Cai,Jiajia Cai et al.
Siyi Wu et al.
Background: Stomach adenocarcinoma (STAD) represents a significant global health challenge, characterized by high heterogeneity in its tumor microenvironment. This study aimed to create a cell composition assessment tool ...
Integrative multi-omics analysis identifies histone methyltransferase SUV420H2 as a prognostic biomarker in clear cell renal cell carcinoma [0.03%]
整合多组学分析鉴定组蛋白甲基转移酶SUV420H2为透明细胞肾细胞癌预后生物标志物
Subhadip Kundu,Rupal Tripathi,Anurag Mehta et al.
Subhadip Kundu et al.
Renal cell carcinoma (RCC) remains a clinically challenging malignancy characterized by high heterogeneity, limited early biomarkers, and suboptimal response rates to current targeted and immune-based therapies. Increasing evidence highligh...
A bibliometric analysis of exosome research in colorectal cancer from 2010 to 2024 [0.03%]
2010年至2024年结直肠癌外泌体研究的文献计量分析
Zimeng Chen,Xuan Xu,Lin Ye
Zimeng Chen
Background: Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide. Exosomes have emerged as key mediators in CRC pathogenesis and progression. However, a systematic overview of the research landscap...
Chk1 inhibition emerges as the most effective partner for PARP inhibition in BRCA-proficient pancreatic cancer [0.03%]
CHK1抑制在BRCA功能正常的胰腺癌中作为PARP抑制的搭档最有效
Yoshihito Morimoto,Yohei Musha,Osamu Takeuchi et al.
Yoshihito Morimoto et al.
Background: PARP inhibitors have shown limited efficacy in pancreatic cancer, partly due to the low prevalence of BRCA mutations, which restricts their clinical use. Because DNA damage checkpoint kinases play critical rol...